Variable name | OR [95% CI] | p value | OR [95% CI] | p value |
---|---|---|---|---|
Infant age at diagnosis n = 2624 | ||||
i. ≤ 6 weeks | 1 (Ref) | 1 (Ref) | ||
ii. >6 weeks – 9 Months | 1.48 [1.09–2.01] | 0.012** | 1.54 [1.03–2.31] | 0.037** |
iii. >9 Months | 4.60 [3.15–6.73] | <0.001** | 3.61 [1.80–7.23] | <0.001** |
Infants’ sex | ||||
Female | 1 (Ref) | |||
Male | 1.22 [0.93–1.60] | 0.152* | 1.16 [0.84–1.59] | 0.368* |
Maternal prophylaxis n = 2244 | ||||
Any form of antiretroviral prophylaxis | 1 (Ref) | 1(Ref) | ||
No antiretroviral prophylaxis | 4.4 [3.2–6.0] | <0.001** | 2.9 [2.0–4.1] | <0.001** |
Maternal antiretroviral regimen (type) n = 2244 | ||||
i. None (did not receive ARVs) | 1 (Ref) | 1(Ref) | ||
ii. HAART | 0.20 [0.14–0.29] | <0.001** | 0.30 [0.19–0.47] | <0.001** |
iii. Interrupted HAART | 0.15 [0.06–0.35] | <0.001** | 0.27 [0.11–0.67] | 0.003** |
iv. AZT + (3TC + sd-NVP at labour) + (AZT + 3TC for 7 days) | 0.23 [0.15–0.34] | <0.001** | 0.41 [0.26–0.65] | <0.001** |
v. SdNVP | 0.06 [0.01–0.47] | 0.007** | 1 | |
vi. Others | 0.37 [0.24–0.58] | <0.001** | 0.49 [0.29–0.82] | 0.005** |
Mode of infant feeding | ||||
Infants ≤ 6 months n= | ||||
Exclusive replacement feeding | 1 (Ref) | 1 (Ref) | ||
Exclusive breastfeeding | 1.28 [0.69–2.38] | 0.4* | 1.27 [0.68–2.38] | 0.456* |
Mixed feeding | 2.75 [1.32–5.70] | 0.007** | 1.73[0.81–3.7] | 0.158* |
Infants >6 months | ||||
Not breastfed | 1 (Ref) | |||
Breast fed | 2.3 [1.3–4.0] | 0.006** | 1.87 [1.02–3.44] | 0.043** |